Testing version — LOERadar is in active testing. Features and data may change.

OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE (AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL) | LOERadar

Viewing data from:

OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE

ANDA

AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL | A203580 | TORRENT PHARMACEUTICALS LTD

5 strengths0 unique patents0 unique exclusivities

Reference Listed Drug: TRIBENZOR

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Oct 28, 2016	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (5)

Sort:

#001 — EQ 5MG BASE;12.5MG;20MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Oct 26, 2016

No patent or exclusivity listings for this strength.

#002 — EQ 5MG BASE;12.5MG;40MG

AB

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Oct 26, 2016

#003 — EQ 5MG BASE;25MG;40MG

AB

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Oct 26, 2016

#004 — EQ 10MG BASE;12.5MG;40MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Oct 26, 2016

#005 — EQ 10MG BASE;25MG;40MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Oct 26, 2016